Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Main Street Capital Corporation (MAIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Main Street Capital Corporation — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.95 (market cap $4.02B), while Main Street Capital Corporation trades at $54.81 (market cap $5.00B). The key difference: Main Street Capital Corporation is the larger of the two by market cap, and Main Street Capital Corporation pays a 5.94% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Main Street Capital Corporation for 89 Days on average.
| EWTX | MAIN | |
|---|---|---|
Market Cap | $4.02B | $5.00B |
Volume | 1,446,128 | 454,409 |
Sector | Health | Financials |
52-Week High | $48.35 | $64.60 |
52-Week Low | $14.89 | $49.63 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $3.56B | $7.48B |
Dividend Yield | — | 5.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Main Street Capital (MAIN) trades at $53.98, up 0.39% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company reported a net income margin of 80.77% for 2025, though revenue dipped to $592 million from $601 million in 2024. Analyst consensus is a $58.00 price target with a Hold-heavy rating mix, while recent news highlights MAIN's strong dividend track record and NAV growth.
The outlook is mixed: MAIN offers a reliable dividend and solid profitability, but near-term earnings softness and a premium valuation pose risks. Investors face headwinds from rising Treasury yields and potential NAV pressure, though long-term income stability remains a key attraction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →
